{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:48:25Z","timestamp":1786999705424,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71082-2","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T09:02:51Z","timestamp":1724835771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of early death in critically ill patients with acute promyelocytic leukaemia in the HICU"],"prefix":"10.1038","volume":"14","author":[{"given":"Haitao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyue","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajuan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"71082_CR1","doi-asserted-by":"publisher","first-page":"992","DOI":"10.18632\/oncotarget.27513","volume":"11","author":"JJ Jimenez","year":"2020","unstructured":"Jimenez, J. J., Chale, R. S., Abad, A. C. & Schally, A. V. Acute promyelocytic leukemia (APL): A review of the literature. Oncotarget 11, 992\u20131003. https:\/\/doi.org\/10.18632\/oncotarget.27513 (2020).","journal-title":"Oncotarget"},{"key":"71082_CR2","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1080\/10428194.2019.1613540","volume":"60","author":"M Stahl","year":"2019","unstructured":"Stahl, M. & Tallman, M. S. Acute promyelocytic leukemia (APL): Remaining challenges towards a cure for all. Leuk. Lymphoma 60, 3107\u20133115. https:\/\/doi.org\/10.1080\/10428194.2019.1613540 (2019).","journal-title":"Leuk. Lymphoma"},{"key":"71082_CR3","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3390\/cancers16061160","volume":"16","author":"A Ghiaur","year":"2024","unstructured":"Ghiaur, A. et al. Acute promyelocytic leukemia: Review of complications related to all-trans retinoic acid and arsenic trioxide therapy. Cancers 16, 1160. https:\/\/doi.org\/10.3390\/cancers16061160 (2024).","journal-title":"Cancers"},{"key":"71082_CR4","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.1016\/j.clml.2020.12.006","volume":"21","author":"R Shein","year":"2021","unstructured":"Shein, R. et al. Outcomes for patients with acute promyelocytic Leukemia in South Africa. Clin. Lymphoma Myeloma Leuk. 21, e348\u2013e352. https:\/\/doi.org\/10.1016\/j.clml.2020.12.006 (2021).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"71082_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1515\/med-2019-0074","volume":"14","author":"R Ciftciler","year":"2019","unstructured":"Ciftciler, R. et al. The factors affecting early death in newly diagnosed APL patients. Open Med. 14, 647\u2013652. https:\/\/doi.org\/10.1515\/med-2019-0074 (2019).","journal-title":"Open Med."},{"key":"71082_CR6","doi-asserted-by":"publisher","first-page":"762653","DOI":"10.3389\/fonc.2021.762653","volume":"11","author":"HH Zhu","year":"2021","unstructured":"Zhu, H. H. et al. Early death and survival of patients with acute promyelocytic Leukemia in ATRA plus Arsenic Era: A population-based study. Front Oncol. 11, 762653. https:\/\/doi.org\/10.3389\/fonc.2021.762653 (2021).","journal-title":"Front Oncol."},{"key":"71082_CR7","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/leu.2011.78","volume":"25","author":"S Lehmann","year":"2011","unstructured":"Lehmann, S. et al. Continuing high early death rate in acute promyelocytic leukemia: A population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia 25, 1128\u20131134. https:\/\/doi.org\/10.1038\/leu.2011.78 (2011).","journal-title":"Leukemia"},{"key":"71082_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.leukres.2013.05.007","volume":"37","author":"JK Altman","year":"2013","unstructured":"Altman, J. K. et al. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death. Leuk. Res. 37, 1004\u20131009. https:\/\/doi.org\/10.1016\/j.leukres.2013.05.007 (2013).","journal-title":"Leuk. Res."},{"key":"71082_CR9","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1182\/blood-2012-08-449918","volume":"121","author":"EM Rego","year":"2013","unstructured":"Rego, E. M. et al. Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL. Blood 121, 1935\u20131943. https:\/\/doi.org\/10.1182\/blood-2012-08-449918 (2013).","journal-title":"Blood"},{"key":"71082_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12185-017-2211-7","volume":"106","author":"IB Hassan","year":"2017","unstructured":"Hassan, I. B. et al. Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE). Int J Hematol. 106, 90\u201398. https:\/\/doi.org\/10.1007\/s12185-017-2211-7 (2017).","journal-title":"Int J Hematol."},{"key":"71082_CR11","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1182\/blood-2011-04-346437","volume":"118","author":"JH Park","year":"2011","unstructured":"Park, J. H. et al. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood 118, 1248\u20131254. https:\/\/doi.org\/10.1182\/blood-2011-04-346437 (2011).","journal-title":"Blood"},{"key":"71082_CR12","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/leu.2017.71","volume":"31","author":"S Lehmann","year":"2017","unstructured":"Lehmann, S. et al. Early death rates remain high in high-risk APL: Update from the Swedish Acute Leukemia Registry 1997\u20132013. Leukemia 31, 1457\u20131459. https:\/\/doi.org\/10.1038\/leu.2017.71 (2017).","journal-title":"Leukemia"},{"key":"71082_CR13","doi-asserted-by":"publisher","first-page":"e9324","DOI":"10.1097\/MD.0000000000009324","volume":"96","author":"F Xu","year":"2017","unstructured":"Xu, F. et al. Analysis of early death in newly diagnosed acute promyelocytic leukemia patients. Medicine 96, e9324. https:\/\/doi.org\/10.1097\/MD.0000000000009324 (2017).","journal-title":"Medicine"},{"key":"71082_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1055\/s-0042-1757303","volume":"12","author":"RP Yedla","year":"2022","unstructured":"Yedla, R. P. et al. Complications during Induction chemotherapy in acute promyelocytic leukemia: An institutional experience. South Asian J. Cancer 12, 274\u2013279. https:\/\/doi.org\/10.1055\/s-0042-1757303 (2022).","journal-title":"South Asian J. Cancer"},{"key":"71082_CR15","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337(2021)","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans, L. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock. Crit. Care Med. 49, e1063\u2013e1143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337(2021) (2021).","journal-title":"Crit. Care Med."},{"key":"71082_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287 (2016).","journal-title":"JAMA"},{"key":"71082_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.leukres.2018.08.004","volume":"73","author":"BL Ferreyro","year":"2018","unstructured":"Ferreyro, B. L. et al. Acute promyelocytic leukemia in the intensive care unit: A retrospective analysis. Leuk. Res. 73, 41\u201343. https:\/\/doi.org\/10.1016\/j.leukres.2018.08.004 (2018).","journal-title":"Leuk. Res."},{"key":"71082_CR18","first-page":"1247","volume":"96","author":"MA Sanz","year":"2000","unstructured":"Sanz, M. A. et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups. Blood 96, 1247\u20131253 (2000).","journal-title":"Blood"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71082-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71082-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71082-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T09:23:27Z","timestamp":1724837007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71082-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71082"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71082-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4072940\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"11 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19987"}}